The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

This 2011 electron microscope image made available by the Centers for Disease Control shows HIV virions. On Wednesday, Sept.

We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that ...

ViiV's Cabenuva is administered every two months and was offered to HIV patients who achieved viral suppression from daily treatments.

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

U2 rock star Bono has been a prominent activist in the global fight against HIV/AIDS, including working with the George W.

South Africa’s government has estimated that universities and science councils could lose about $107 million in U.S. research ...

French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...